Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
all decrease » small decrease (Expand Search), fold decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
all decrease » small decrease (Expand Search), fold decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1621
Death rate and difference for Sex across Age without (A, C) or with (B, D) adjustment.
Published 2025Subjects: -
1622
Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage.
Published 2025Subjects: -
1623
-
1624
-
1625
-
1626
-
1627
-
1628
Statins resulted in smaller neuronal soma size.
Published 2025“…Areas of all BrdU + /Hu+ neurons measured in control birds (dark orange line) and statin-treated birds (light orange line) shows qualitatively that statins did not decrease soma sizes of small cells (overlap of orange lines), and statins did not curtail the upper limit of soma size (light orange line reaches a soma size of > 200 µm, Y axis, top panel). …”
-
1629
-
1630
-
1631
-
1632
-
1633
-
1634
-
1635
Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function.
Published 2024“…For panel B, error bars represent the standard error of the mean (<i>n</i> = 25), and statistical significance was analyzed by one-way ANOVA with a Tukey post hoc test (*<i>p</i> < 0.05 and **<i>p</i> < 0.01). …”
-
1636
Overexpression of MALS-1 reduces mitochondria in the PLM axon and causes axon degeneration and axon overlap defects.
Published 2024“…<p>(A–C) Overexpressed MALS-1::Scarlet protein colocalizes with mitochondria. …”
-
1637
-
1638
-
1639
-
1640